1. Elizabeth K. Bancroft, Rosalind A. Eeles
Corrigendum to “Targeted Prostate Cancer Screening in BRCA1 and BRCA2 Mutation Carriers: Results from the Initial Screening Round of the IMPACT Study” [Eur Urol 2014;66:489–99] 
Elizabeth K. Bancroft, Rosalind A. Eeles 
European Urology 
Volume 67, Issue 6, (June 2015)
DOI: /j.eururo
Copyright © 2014 European Association of Urology Terms and Conditions

2. Fig. 2
Consort diagram for the first round of screening. BRCA1=breast cancer 1, early onset; BRCA2=breast cancer 2, early onset; PSA=prostate-specific antigen; PPV=positive predictive value. * Controls were men who had a negative predictive genetic test for the BRCA mutation in their family.
European Urology  , DOI: ( /j.eururo )
Copyright © 2014 European Association of Urology Terms and Conditions